UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin Journal article
Chisholm C.L., Wang H., Wong A.H.-H., Vazquez-Ortiz G., Chen W., Xu X., Deng C.-X.. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin[J]. Oncotarget, 2016, 7(51), 84439-84452.
Authors:  Chisholm C.L.;  Wang H.;  Wong A.H.-H.;  Vazquez-Ortiz G.;  Chen W.; et al.
Favorite | TC[WOS]:46 TC[Scopus]:49  IF:5.168/5.312 | Submit date:2018/12/13
Atp7a  Breast Cancer  Cisplatin  Copper  Resistance  Sequestering  
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells Journal article
Vazquez-Ortiz G., Chisholm C., Xu X., Lahusen T.J., Li C., Sakamuru S., Huang R., Thomas C.J., Xia M., Deng C.. Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells[J]. Breast Cancer Research, 2014, 16(3).
Authors:  Vazquez-Ortiz G.;  Chisholm C.;  Xu X.;  Lahusen T.J.;  Li C.; et al.
Favorite | TC[WOS]:20 TC[Scopus]:22 | Submit date:2018/12/13
Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis Journal article
Kim H.-S., Xiao C., Wang R.-H., Lahusen T., Xu X., Vassilopoulos A., Vazquez-Ortiz G., Jeong W.-I., Park O., Ki S.H., Gao B., Deng C.-X.. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis[J]. Cell Metabolism, 2010, 12(3), 224-236.
Authors:  Kim H.-S.;  Xiao C.;  Wang R.-H.;  Lahusen T.;  Xu X.; et al.
Favorite | TC[WOS]:410 TC[Scopus]:440 | Submit date:2018/12/13